Osian A D, Anderson L L, Linares L A, Nori D, Hilaris B S
Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
Int J Radiat Oncol Biol Phys. 1989 Jan;16(1):219-23. doi: 10.1016/0360-3016(89)90034-5.
Nine patients who were presented at MSKCC with primary or recurrent pelvic or head and neck tumors and for whom surgery or further external radiation were excluded, were treated with percutaneous permanent or temporary implants, with individual pre-treatment planning and custom made templates. The tumor dose distributions achieved were as good as for implants performed at the time of surgical exploration. No serious complications have been encountered.
9例因原发性或复发性盆腔或头颈部肿瘤就诊于纪念斯隆凯特琳癌症中心(MSKCC)且被排除手术或进一步外照射治疗的患者,接受了经皮永久性或临时性植入治疗,并进行了个体化的治疗前规划和定制模板。所实现的肿瘤剂量分布与手术探查时进行的植入治疗效果相当。未出现严重并发症。